Linked Life Data

10786040

Source:http://linkedlifedata.com/resource/pubmed/id/10786040

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2000-6-13
pubmed:abstractText
Dihyroartemesinin, an artemesinin derivative, was used for treatment of mice experimentally infected with S. mansoni. A significant decrease in total worm count was recorded when mice were treated during early and late stages of infection. Histopathological examination of liver sections showed minimal pathological changes with early treatment and enhanced fibrosis of granulomas with late treatment. The results showed that dihydroartemesinin had a promising effect on S. mansoni infected mice almost comparable to that of praziquantel.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0253-5890
pubmed:author
pubmed:issnType
Print
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
295-303
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Experimental trials of an artemisinin derivative in treatment of Schistosoma mansoni infected mice.
pubmed:affiliation
Department of Parasitology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
pubmed:publicationType
Journal Article